MRD No. : 0014742 Reg No.

: GMC-A-348527
Patient Name : MRS ANKITA SHRIVASTAV Path No : 7,582

Age & Sex : 30 Years / Female Sample Drawn Date : 26/05/2022 08:31:25
Referring Doctor : DR. VIBHA ARORA 26-05-2022 12:54:13
Report Date :

HAEMATOLOGY REPORT
DESCRIPTION VALUE OBSERVED UNITS REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN(HBA1C)

GLYCOSYLATED : 5.2 % Non -Diabetic: < = 5.6

Pre - Diabetic: 5.7- 6.4
HAEMOGLOBIN(HBA1C)
Diabetic : > = 6.5

eAG (Estimated Average : 102.54 mg/dL

Glucose)
Sample type : EDTA whole blood.
Method : HPLC
1) HBA1C testing is recommended for monitoring blood sugar control in patients with diabetes mellitus. The HBA1C level is
proportional to average blood glucose concentration over the previous 4wks to 3months.
2) HBA1C assesses the effectiveness of therapy by monitoring the long term plasma glucose concentration .
3) eAG ( Estimated Average Glucose)= 28.7 X A1C% - 46.7.
4) Lower than expected HbA1C levels seen in patients with reduced RBC life span like sickle cell disease, G6PD
deficiency.
5) Higher than expected HbA1C levels seen in Vitamin B12 and Folic Acid deficiency.
6) In Diabetics with hemolytic anaemias fructosamine levels may be used which reflects an average plasma glucose
overthe preceding 2-3 weeks.
7) In known diabetic patients , following values can be considered as a tool for monitoring the glycemic control.
Excellent control - 6 to 7 %
Fair to Good control - 7 to 8 %
Unsatisfactory contol - 8 to 10 %
Poor control - More than 10 %

This is computer generated medical diagnostics report that has been

validated by an Authorized Medical Doctor.
Dr. ARCHANA BELEKAR
The report does not need physical signature.
MD, DNB,DPB

Page 1 of 5
MRD No. : 0014742 Reg No. : GMC-A-348527
Patient Name : MRS ANKITA SHRIVASTAV Path No : 7,582

Age & Sex : 30 Years / Female Sample Drawn Date : 26/05/2022 08:31:25
Referring Doctor : DR. VIBHA ARORA 26-05-2022 13:24:01
Report Date :

BIOCHEMISTRY REPORT
DESCRIPTION VALUE OBSERVED UNITS REFERENCE RANGE

BLOOD SUGAR ( FASTING )

Blood Sugar ( F ) : 90.9 mg/dL 70-100

Estimation of Plasma Glucose by Hexokinase Method.

Impaired GlucoseTolerance : Fasting blood sugar > 100 mg/dL but < 126 mg/dL in non pregnant adult.
Diabetes mellitus >=126 mg/dL on more than one occasion.{ American Diabetes Association Guidelines 2015 }

This is computer generated medical diagnostics report that has been

validated by an Authorized Medical Doctor.
Dr. ARCHANA BELEKAR
The report does not need physical signature.
MD, DNB,DPB

Page 2 of 5
MRD No. : 0014742 Reg No. : GMC-A-348527
Patient Name : MRS ANKITA SHRIVASTAV Path No : 7,582

Age & Sex : 30 Years / Female Sample Drawn Date : 26/05/2022 08:31:25
Referring Doctor : DR. VIBHA ARORA 26-05-2022 13:58:49
Report Date :

IMMUNOASSAY REPORT
DESCRIPTION VALUE OBSERVED UNITS REFERENCE RANGE

TSH

: 1.4090 uIU/mL 0.27-4.2

Thyroid Stimulating Hormone
(Ultra TSH)
Sample type : Serum.
Values in the range of 4.2-15 uIU/mL - suggested clinical corelation or repeat the test with new sample as physiological factors
can give falsely high TSH.
Hormonal assay performed by CLIA on Unicel DxI - 800 (BECKMAN).

Remarks:
1. TSH values may be transiently altered because of non thyroidal illness like severe infections, liver disease, renal and
heart failure, severe burns, trauma and surgery etc
2. Drugs that decrease TSH values e.g.: L-dopa, Glucocorticoids Drugs that increase TSH values e.g. : Iodine, Lithium,
Amiodarone.
3. Serum TSH levels exhibit diurnal variation with the peak during the night and the nadir which is approx 50 % of the peak
value , occuring between 1000 hrs to 1600 hrs.

TSH recommendations in pregnancy :

1st Trimester 0.1 – 2.5
2nd Trimester 0.2 – 3.0
3rd Trimester 0.3 – 3.0
* The linerarity range of Unicel DxI -800 increased upto 500 mIU/ mL .

This is computer generated medical diagnostics report that has been

validated by an Authorized Medical Doctor.
Dr. ARCHANA BELEKAR
The report does not need physical signature.
MD, DNB,DPB

Page 3 of 5
MRD No. : 0014742 Reg No. : GMC-A-348527
Patient Name : MRS ANKITA SHRIVASTAV Path No : 7,582

Age & Sex : 30 Years / Female Sample Drawn Date : 26/05/2022 08:31:25
Referring Doctor : DR. VIBHA ARORA 26-05-2022 14:18:04
Report Date :

IMMUNOASSAY REPORT
DESCRIPTION VALUE OBSERVED UNITS REFERENCE RANGE

AMH (ANTI MULLERIAN HORMONE)

AMH (ANTI MULLERIAN HORMONE)
ANTI MULLERIAN HORMONE : 3.52 ng/mL 0.9-9.5

TEST METHOD : ECLIA

Method: ECLIA ON ACCESS-2/ Unicel DxI( BECKMAN)

INTERPRETATION:

Anti-Mullerian Hormone is a dimeric glycoprotein belonging to the transforming growth factor- ß family.
In males : It is secreted by sertoli cells of the testes. It can distinguish undescended testes with normal AMH from
anorchia which have very low AMH. In infants with intersex or ambiguous genitalia, it helps to evaluate testicular presence
and functions.
In females : AMH expression is observed at 36 weeks gestation in granulosa cells of preantral ovarian follicles and is
produced until menopause. AMH concentration in adult females reflect the number of small follicles entering the growth
phase of their life cycle or the ovarian reserve. The day to day variability in menstruating women is so low that it can be
measured at any day during the menstrual cycle.
AMH has been used in the evaluation of ovarian reserve primarily to predict an infertile women's response to controlled
ovarian stimulation.
It can be used to diagnose and monitor women with polycystic ovary syndrome. AMH concentrations are elevated in
normogonadotrophic anovulation women with PCOS.
Granulosa cell tumors of the ovary associated with high AMH .
AMH helps differentiate between gonadal and non-gonadal causes of mild virilization. Extremely high values found in girls
with virilizing sertoli leyding cell tumors.
Studies in various fertility clinics are ongoing to establish optimal AMH concentrations for predicting response to invitro
fertilization.
Given below is suggested interpretative reference -

Optimal fertility - Above 4.0 ng/mL.

Satisfactory fertility - 2.19 - 4.0 ng/mL.
Low fertility - 0.3 - 2.19 ng/mL.
Very low/undetectable below - 0.3 ng/mL.

B-HCG

This is computer generated medical diagnostics report that has been

validated by an Authorized Medical Doctor.
Dr. ARCHANA BELEKAR
The report does not need physical signature.
MD, DNB,DPB

Page 4 of 5
MRD No. : 0014742 Reg No. : GMC-A-348527
Patient Name : MRS ANKITA SHRIVASTAV Path No : 7,582

Age & Sex : 30 Years / Female Sample Drawn Date : 26/05/2022 08:31:25
Referring Doctor : DR. VIBHA ARORA 26-05-2022 13:51:56
Report Date :

B-HCG SERUM : 0.65 mIU/mL Refer the footnote.

Method ECLIA On Access 2 / Unicel DxI (Beckman)

Reference Range :
In Pregnant Patients :
Gestational Wks : mIU/mL.
3 : 5.4 to 72
4 : 10.2 to 708
5 : 217 to 8245
6 : 152 to 32,177
7 : 4059 to 153,767
8 : 31,366 to 149,094
9 : 59,109 to 135,901
10 : 44,186 to 170,409
12 : 27,107 to 201,615
14 : 24,302 to 93,646
15 : 12,540 to 69,747
16 : 8904 to 55,332
17 : 8240 to 51,793
18 : 9649 to 55,271
Values are Less then 5.3 mIU/mL in patients who are not pregnant.
PROLACTIN

PROLACTIN BY (ECLIA) : 21.50 ng/mL Refer the footnote.

Sample type : Serum.

Hormonal assay performed by CLIA on Unicel DxI - 800 / (Beckman)
Female:Non Pregnant-1.2 - 15.5 ng/mL.Menopausal 1.5 - 18.5 ng/mL.Males 1.8-17.0 ng/mL.As various drugs &
physiological factors can give falsely elevated levels, high result should be rechecked with new sample.
Prolactin is secreted by the anterior cells of the pituitary gland and is required for normal breast development and lactation
in women. Normal Prolactin secretion varies with time which results in levels 2-3 lines higher at nigh than during the day
hyper Prolactinaemia is associated with inhibition of ovarian steroidgenesis, follicle maturation and secretion of LH and
FSH.

Psychotropic drugs (Phenothaizines ), reserpine and TRH tend to increase PRL secretion.

This is computer generated medical diagnostics report that has been

validated by an Authorized Medical Doctor.
Dr. ARCHANA BELEKAR
The report does not need physical signature.
MD, DNB,DPB

Page 5 of 5